Veradigm (NASDAQ:MDRX) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRXFree Report) in a report released on Wednesday. The brokerage issued a hold rating on the software maker’s stock.

Separately, Stephens lifted their target price on shares of Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research report on Friday, January 31st.

Check Out Our Latest Stock Report on MDRX

Veradigm Stock Performance

Shares of MDRX stock opened at $4.25 on Wednesday. Veradigm has a fifty-two week low of $4.00 and a fifty-two week high of $11.80. The business has a fifty day simple moving average of $5.30 and a 200-day simple moving average of $8.19.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Stories

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.